Available globally, CoVive works to relieve pressure on healthcare systems to help 'flatten the curve'. By empowering users with more clarity and information about their health, with features for self-assessment, test interpretation, and self-monitoring, the app acts as a reassuring companion and source of reliable information and proposed next steps for users.
From its HQ in Luxembourg, BioneXt worked closely with Medicus AI to customize and localize CoVive to multiple countries, and in multiple languages, always supported by official local guidelines and local sources to provide relevant and up-to-date information that is in line with each country's guidelines, contact information, and recommendations.
CoVive is a regulated medical product and is the first SARS-CoV-2 app to receive a CE medical device class 1 certification.
The CoVive platform is powered by Medicus AI, a global digital healthcare company working with diagnostic labs, clinics, and insurers that offers a range of medical and CE certifiedproducts in its portfolio. Medicus AI was advised by ABA – Invest in Austria when setting up its Viennese headquarters.
Find out how we can support your international startup in Austria!